Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019064164) PERGOLIDE FOR USE IN THE TREATMENT OF EYE DISEASES ASSOCIATED WITH AN ELEVATED LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND PHARMACEUTICAL COMPOSITION CONTAINING PERGOLIDE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/064164 International Application No.: PCT/IB2018/057378
Publication Date: 04.04.2019 International Filing Date: 25.09.2018
IPC:
A61K 31/48 (2006.01) ,A61P 27/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
48
Ergoline derivatives, e.g. lysergic acid, ergotamine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27
Drugs for disorders of the senses
Applicants:
OSĘKA, Maciej [PL/PL]; PL
Inventors:
OSĘKA, Maciej; PL
ZUBILEWICZ, Anna; PL
Agent:
DARGIEWICZ, Joanna; PL
Priority Data:
PL42297826.09.2017PL
Title (EN) PERGOLIDE FOR USE IN THE TREATMENT OF EYE DISEASES ASSOCIATED WITH AN ELEVATED LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND PHARMACEUTICAL COMPOSITION CONTAINING PERGOLIDE
(FR) PERGOLIDE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE MALADIES OCULAIRES ASSOCIÉES À UN TAUX ÉLEVÉ DU FACTEUR DE CROISSANCE ENDOTHÉLIALE VASCULAIRE (VEGF) ET COMPOSITION PHARMACEUTIQUE CONTENANT DU PERGOLIDE
Abstract:
(EN) The object of the invention is pergolide for use in the treatment of eye diseases associated with an elevated level of vascular endothelial growth factor (VEGF) and a pharmaceutical composition for use in the treatment of eye diseases associated with an elevated level of vascular endothelial growth factor (VEGF), characterised in that it contains pergolide and a pharmaceutically acceptable carrier.
(FR) L'invention concerne un composé pergolide destiné à être utilisé dans le traitement de maladies oculaires associées à un taux élevé du facteur de croissance endothéliale vasculaire (VEGF), et une composition pharmaceutique destinée à être utilisée dans le traitement de maladies oculaires associées à un taux élevé du facteur de croissance endothéliale vasculaire (VEGF), ladite composition étant caractérisée en ce qu'elle contient le composé pergolide et un excipient pharmaceutiquement acceptable.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: Polish (PL)